|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
|
|---|---|---|---|---|---|---|---|
| Cash and due from banks | |||||||
| Interest-bearing deposits with banks | |||||||
| Loans receivable | |||||||
| Less allowance for credit losses | |||||||
| Loans receivable, net | |||||||
| Accrued interest receivable | |||||||
| Property and equipment, net | |||||||
| Federal Home Loan Bank stock, at cost | |||||||
| Other assets | |||||||
| TOTAL ASSETS | |||||||
| LIABILITIES | |||||||
| Interest bearing deposits | |||||||
| Noninterest-bearing deposits | |||||||
| Advances from Federal Home Loan Bank | |||||||
| Total deposits | |||||||
| Advance payments by borrowers for insurance and taxes | |||||||
| Accrued interest payable | |||||||
| Accrued expense and other liabilities | |||||||
| Deferred tax liability, net | |||||||
| Total Liabilities | |||||||
| STOCKHOLDERS' EQUITY | |||||||
| Preferred stock, $.01 par value - 2,000,000 shares authorized, none issued | |||||||
| Common Stock, $.01 par value - 6,000,000 shares authorized; 832,288 and 833,750 issued and outstanding at June 30, 2026 and December 31, 2025, respectively | |||||||
| Additional paid-in capital | |||||||
| Unearned ESOP stock- 63,365 and 64,476 shares at June 30, 2026 and December 31,2025, respectively | |||||||
| Retained earnings | |||||||
| Total Stockholders' Equity | |||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY |
Loading...
